Steinar Aamdal

8.8k citations
116 papers · 7.3k · 2 hit papers · h-index 41

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management
    • Lung Cancer Research Studies
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cancer Immunotherapy and Biomarkers 18
    • Cutaneous Melanoma Detection and Management 12
    • CAR-T cell therapy research 7
    • Lung Cancer Research Studies 6
    • Cancer Treatment and Pharmacology 6
    • Cancer Cells and Metastasis 6
    • Immunotherapy and Immune Responses 27
    • Toxin Mechanisms and Immunotoxins 7

Steinar Aamdal

115 papers receiving 7.0k citations

Steinar Aamdal's Hit Papers

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial 2015 · 407 citations
4070+8+17Years since publication2505007501000

Peers

Steinar Aamdal
Comparison fields: 5 of 131
  • Oncology 3.9k
  • Immunology 2.2k
  • Molecular Biology 2.7k
  • Biotechnology 327
  • Pulmonary and Respiratory Medicine 957
Replace Ester Simeone with:
Ester Simeone Italy
Hartmut Koeppen United States
Luis H. Camacho United States
Emina H. Huang United States
Stefania Scala Italy
Agop Y. Bedikian United States
Kari Lynn Kendra United States
Lawrence E. Flaherty United States
Chris H.M. Takimoto United States
Mariano Ponz‐Sarvisé Spain
Steinar Aamdal relative to Ester Simeone Italy Ester Simeone's profile →
Citations per field
00.5×1.5×
Ester Simeone · 1×
Citations per year

Countries citing papers authored by Steinar Aamdal

Since Specialization
Citations

This map shows the geographic impact of Steinar Aamdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steinar Aamdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steinar Aamdal more than expected).

Fields of papers citing papers by Steinar Aamdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steinar Aamdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steinar Aamdal. The network helps show where Steinar Aamdal may publish in the future.

Co-authors

The 25 scholars most cited alongside Steinar Aamdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steinar Aamdal Line = papers co-authored together Steinar Aamdal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
Hit paper breakdown →
20001038
2 2011472
3
Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
Hit paper breakdown →
2015407
4 2004396
5 2002376
6 2013272
7 2006206
8
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.
1992181
9 2006174
10 2003153
11 1998147
12 2002142
13 2011140
14 2011138
15 2004130
16 2013122
17 201197
18 198897
19 201390
20 201185

About Steinar Aamdal

Steinar Aamdal is a scholar working on Oncology, Immunology, Cancer Research, Biotechnology and Molecular Biology, having authored 116 papers that have together received 7.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (27 papers), Cancer Immunotherapy and Biomarkers (18 papers), Cutaneous Melanoma Detection and Management (12 papers), CAR-T cell therapy research (7 papers), Toxin Mechanisms and Immunotoxins (7 papers), Lung Cancer Research Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Oncology (3.9k citations), Immunology (2.2k citations), Molecular Biology (2.7k citations), Biotechnology (327 citations) and Pulmonary and Respiratory Medicine (957 citations). Steinar Aamdal has collaborated with scholars based in Norway, United Kingdom and Netherlands. Frequent co-authors include Gustav Gaudernack, Øystein Fodstad, Alexander Pihl, Jean‐Jacques Grob, Gunnar Kvalheim, Stein Harald Sundstrøm, Jon Amund Kyte, Paal Fr Brunsvig, Roy Martin Bremnes and Stein Kaasa. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, British Journal of Cancer and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact